| 2007 |
ZBP1/DAI (DLM-1) binds double-stranded DNA directly and, upon binding, enhances its association with IRF3 transcription factor and TBK1 serine/threonine kinase to activate type I interferon gene expression. siRNA knockdown of ZBP1 inhibited DNA-mediated innate immune gene induction, establishing ZBP1 as a cytosolic DNA sensor upstream of the IRF3-TBK1 axis. |
siRNA knockdown, co-immunoprecipitation, overexpression in mouse fibroblasts, reporter assays |
Nature |
High |
17618271
|
| 2001 |
Crystal structure of the DLM-1 (ZBP1) Zα domain bound to left-handed Z-DNA at 1.85 Å resolution revealed a winged-helix fold and a conserved Z-DNA recognition core shared with ADAR1 Zα, defining a family of Z-DNA-binding proteins with a common structure-specific recognition mechanism. |
X-ray crystallography |
Nature structural biology |
High |
11524677
|
| 2008 |
ZBP1/DAI requires three DNA-binding domains (Zα1, Zα2, and D3) for full activation of type I IFN in vivo; artificially induced dimerization of DAI causes DNA-independent activation of type I IFN genes, indicating dimerization is a key step in DAI activation. |
Mutational analysis of DNA-binding domains, forced dimerization constructs, reporter assays, in vitro DNA binding |
Proceedings of the National Academy of Sciences of the United States of America |
High |
18375758
|
| 2009 |
ZBP1/DAI contains two RIP homotypic interaction motifs (RHIMs) that recruit RHIM-containing kinases RIPK1 and RIPK3 to relay NF-κB activation signals downstream of cytosolic DNA sensing. RIPK3 knockdown, like RIPK1 knockdown, reduces DAI-induced NF-κB activation. The MCMV protein M45 inhibits RIP recruitment to DAI via its own RHIM domain. |
Co-immunoprecipitation, siRNA knockdown of RIPK1/RIPK3, NF-κB reporter assays, RHIM domain identification by sequence analysis |
EMBO reports |
High |
19590578
|
| 2012 |
ZBP1/DAI forms a complex with RIPK3 via RHIM-dependent interactions to mediate virus-induced programmed necrosis during MCMV infection. DAI-deficient cells and mice are resistant to MCMV-induced necrosis, and the MCMV vIRA protein suppresses this pathway by targeting the DAI-RIP3 complex. |
Co-immunoprecipitation, DAI knockdown/knockout cells, Zbp1−/− mouse genetics, viral pathogenesis assays |
Cell host & microbe |
High |
22423968
|
| 2016 |
ZBP1 senses influenza A virus genomic RNA (vRNPs) and associates with RIPK3, recruiting MLKL and RIPK1 to RIPK3 to trigger both necroptosis and apoptosis. DAI-deficient cells and mice fail to activate RIPK3 in response to IAV, establishing DAI as the link between IAV RNA and RIPK3 activation. |
DAI knockout/knockdown cells, RIPK3 co-immunoprecipitation, cell death assays, Zbp1−/− mouse infection model |
Cell host & microbe |
High |
27746097
|
| 2016 |
RIPK1's RHIM domain prevents ZBP1 from binding and activating RIPK3; mutation of RIPK1 RHIM (IQIG→AAAA) allows ZBP1 to interact with phosphorylated RIPK3, causing ZBP1-RIPK3-MLKL-dependent necroptosis and perinatal lethality. ZBP1 deficiency prevents necroptosis and skin inflammation in RIPK1-RHIM-mutant and epidermis-specific RIPK1-KO mice. |
RHIM knock-in mouse genetics, Co-immunoprecipitation, Zbp1−/− mouse genetics, histopathology |
Nature |
High |
27819681 27819682
|
| 2016 |
The RIPK1 RHIM acts as a brake preventing ZBP1 from engaging RIPK3's RHIM; in RIPK1-RHIM mutant (IQIG→AAAA) mice, ZBP1 constitutively interacts with RIPK3 (but not in WT or RIPK3-RHIM mutant cells), driving RIPK3 autophosphorylation (Thr231/Ser232) and MLKL-dependent perinatal lethality. |
Knock-in mouse genetics (Ripk1RHIM/RHIM), Co-immunoprecipitation of ZBP1-RIPK3, Zbp1−/− genetic rescue, Western blot for pRIPK3 |
Nature |
High |
27819682
|
| 2017 |
ZBP1 directly binds RNA via its Zα domains; mutation of key amino acids in Zα1 and Zα2 required for Z-nucleic acid binding abolished ZBP1-mediated necroptosis during MCMV infection and upon ZBP1 overexpression. Cell death required RNA synthesis but not viral DNA replication, implicating Z-RNA as the ZBP1 ligand. |
Reconstitution/knock-in models with ZBP1 Zα domain mutations, MCMV infection cell death assays, RNA cross-linking, viral replication inhibitor experiments |
The EMBO journal |
High |
28716805
|
| 2017 |
ZBP1 activation during IAV infection requires upstream RIG-I-MAVS-IFN-β signaling; ZBP1 undergoes ubiquitination after IAV infection as a post-translational modification. ZBP1 senses IAV vRNP complexes (not free RNA) to trigger programmed cell death. |
RIG-I/MAVS KO cells, IFN-β signaling inhibition, ubiquitination assays, vRNP pulldown, cell death assays |
The Journal of experimental medicine |
Medium |
28634194
|
| 2017 |
The N-terminal domain of ZBP1 mediates ZBP1-ZBP1 homointeraction, and the RHIM domain in the C-terminal region interacts with RIPK3 to initiate RIPK3-dependent necroptosis downstream of IFN stimulation. |
Domain deletion constructs, co-immunoprecipitation of ZBP1 self-interaction and ZBP1-RIPK3, IFN-induced necroptosis assays in RIPK1/FADD/caspase-8 KO cells |
Cellular & molecular immunology |
Medium |
31076724
|
| 2017 |
MCMV requires viral IE3-dependent early transcription (not input virion DNA or newly synthesized viral DNA) for DAI/ZBP1-mediated necroptosis; the Zα2 domain of DAI/ZBP1 is required for sensing MCMV and triggering necroptosis, implicating viral RNA transcripts as the relevant ligand. |
Viral mutants blocking DNA replication/IE3 transcription, Zα2 domain mutation of ZBP1, necroptosis assays |
EMBO reports |
Medium |
28607035
|
| 2019 |
ZBP1 and RIPK3 activation in ZIKV-infected neurons does not induce necroptosis but instead restricts viral replication by upregulating the enzyme IRG1, leading to itaconate production that inhibits succinate dehydrogenase and suppresses viral genome replication via an immunometabolic mechanism. |
ZBP1/RIPK3 KO murine neurons, ZIKV infection model, metabolomics, IRG1 KO, itaconate supplementation |
Immunity |
High |
30635240
|
| 2019 |
ZBP1/DAI drives RIPK3-mediated cell death (necroptosis and apoptosis) in response to IFNs in the absence of RIPK1; IFN-activated JAK/STAT signaling induces ZBP1 expression, which then complexes with RIPK3 to trigger caspase-8-mediated apoptosis and MLKL-driven necroptosis. |
Zbp1−/− genetics in Ripk1−/− background, JAK/STAT inhibitors, ZBP1-RIPK3 co-immunoprecipitation, Ripk1−/− mouse survival studies |
Journal of immunology |
Medium |
31358656
|
| 2020 |
Replicating influenza A virus generates Z-RNAs that activate ZBP1 in the nucleus of infected cells; nuclear ZBP1 then initiates RIPK3-mediated MLKL activation in the nucleus, causing nuclear envelope disruption, DNA leakage into cytosol, and 'inside-out' necroptosis. Nuclear MLKL activation potently activates neutrophils. |
Z-RNA detection in IAV-infected cells, RIPK3/MLKL nuclear localization by imaging, MLKL-deficient mice, neutrophil recruitment assays, survival studies |
Cell |
High |
32200799
|
| 2020 |
Zα-domain-dependent sensing of endogenous Z-form nucleic acids (Z-DNA/Z-RNA) by ZBP1 triggers RIPK3-dependent necroptosis and inflammation in the absence of viral infection. ZBP1 constitutively binds cellular double-stranded RNA in a Zα-dependent manner; inhibition of nuclear export triggers Zα-dependent RIPK3 activation in the nucleus. Endogenous retroelement-derived dsRNA is implicated as a Zα-domain ligand. |
Ripk1mR/mR and RIPK1E-KO and FADDIEC-KO mouse models with Zbp1−/− genetic rescue, nuclear export inhibition, Zα domain mutagenesis, ZBP1 RNA cross-linking |
Nature |
High |
32296175
|
| 2021 |
ADAR1 interacts with the Zα2 domain of ZBP1 to suppress ZBP1-RIPK3 interactions and thereby limit ZBP1-mediated PANoptosis. Deletion of ADAR1 (Adar1fl/fl LysMcre) increases ZBP1-dependent cell death; deletion of the ZBP1 Zα2 domain restores tumorigenesis in ADAR1-deficient mice, demonstrating ADAR1 acts as a negative regulator of ZBP1 via Zα2-domain interaction. |
Co-immunoprecipitation of ADAR1-ZBP1, Zα2 domain deletion knock-in mice, conditional ADAR1 KO, tumor models, PANoptosis assays |
Cell reports |
High |
34686350
|
| 2021 |
AIM2 regulates ZBP1 as part of a large multi-protein PANoptosome complex including AIM2, pyrin, ZBP1, ASC, caspase-1, caspase-8, RIPK3, RIPK1, and FADD; this complex drives inflammatory cell death (PANoptosis). AIM2 is required for ZBP1 integration into the complex during HSV-1 and F. novicida infection. |
Co-immunoprecipitation of multi-protein complex, AIM2/ZBP1/pyrin KO genetics, infectious disease mouse models, cell death assays |
Nature |
High |
34471287
|
| 2022 |
ADAR1 prevents accumulation of endogenous Z-RNAs (from Alu inverted repeat dsRNAs); loss of ADAR1's Zα domain causes ZBP1 activation leading to caspase-8-dependent apoptosis and MLKL-mediated necroptosis. ZBP1 ablation fully rescues overt pathology caused by ADAR1 Zα-domain mutation, positioning ADAR1 as a negative regulator of sterile ZBP1 activation. |
Adar−/− and Adar1mZα/− mouse genetics combined with Zbp1−/− rescue, cell death assays, RNA-seq for Alu elements |
Nature |
High |
35859175 35859176 35859177
|
| 2022 |
ADAR1 depletion or mutation results in Z-RNA accumulation and ZBP1 activation culminating in RIPK3-mediated necroptosis. The small molecule CBL0137 activates ZBP1 by triggering Z-DNA formation in cells, inducing ZBP1-dependent necroptosis in cancer-associated fibroblasts. |
ADAR1 KO/mutation in cancer cell lines, Z-RNA detection, ZBP1 KO controls, small molecule (CBL0137) treatment, tumor models |
Nature |
High |
35614224
|
| 2021 |
Vaccinia virus protein E3 prevents ZBP1-mediated necroptosis by competing for Z-form RNA through its N-terminal Zα domain; in the absence of the E3 Zα domain, Z-form RNA accumulates during early VACV infection, triggering ZBP1 to recruit RIPK3 and execute RIPK3-MLKL-dependent necroptosis. Substitution of Zα domains from ZBP1 or ADAR1 into E3 restores necroptosis suppression. |
E3 Zα mutant VACV, Z-RNA detection, ZBP1/RIPK3/MLKL KO cell lines, domain swap experiments |
Cell host & microbe |
High |
34192517
|
| 2021 |
ZBP1 constitutive binding to RIPK1 is essential for TRIFosome (FADD-RIPK1-caspase-8 complex) formation, caspase-8-mediated cell death, and inflammasome activation in response to LPS and Yersinia pseudotuberculosis, positioning ZBP1 as an effector of the TRIF-dependent cell death pathway. |
ZBP1 KO cells/mice, co-immunoprecipitation of ZBP1-RIPK1, LPS and Yersinia infection models, caspase-8 and inflammasome activity assays |
Nature communications |
Medium |
33397971
|
| 2022 |
ZBP1 promotes TLR3/TLR4-mediated inflammatory responses by facilitating timely delivery of RIPK1 to TRIF and enabling M1-ubiquitination of RIPK1, sustaining downstream inflammatory signaling cascades; Zbp1−/− mice show resistance to LPS-induced septic shock. |
Zbp1−/− mouse LPS sepsis model, co-immunoprecipitation of ZBP1-RIPK1-TRIF complex, RIPK1 ubiquitination assays |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
35666872
|
| 2022 |
In human cells, ZBP1 associates with RIPK1, RIPK3, and ubiquitin ligases cIAP1 and LUBAC; ZBP1 promotes K63- and M1-linked ubiquitination of RIPK1 and ZBP1 itself via RIPK1 and RIPK3 as scaffolds (independently of their kinase activity) to activate TAK1- and IKK-mediated inflammatory signaling and cytokine production. |
Co-immunoprecipitation of ZBP1-RIPK1-RIPK3-cIAP1-LUBAC, ubiquitin chain-specific pulldowns, kinase-dead RIPK1/RIPK3 mutants, cytokine production assays in HT29 cells |
EMBO reports |
Medium |
36268590
|
| 2022 |
Caspase-8 and FADD suppress spontaneous ZBP1 expression and thereby prevent spontaneous RIPK3-MLKL activation and necroptosis; in Caspase-8-deficient cells, increased ZBP1 expression is maintained by a positive feedback loop requiring cGAS-STING-TBK1 signaling. ZBP1 deletion suppresses spontaneous MLKL phosphorylation in Casp8−/− mice in vivo. |
Casp8−/− and FADD−/− mouse genetics, Zbp1−/− rescue, FLAG-MLKL knock-in reporter model, cGAS/STING/TBK1 inhibition, ZBP1 reconstitution |
Proceedings of the National Academy of Sciences of the United States of America |
High |
36191211
|
| 2023 |
ZBP1 stabilizes Z-form mitochondrial DNA (mtDNA) and nucleates a cytosolic complex containing cGAS, RIPK1, and RIPK3 on destabilized mitochondrial genomes to sustain STAT1 phosphorylation and type I IFN signaling. ZBP1-deficient mice are protected from doxorubicin-induced cardiotoxicity. |
ZBP1 KO mice, Z-DNA detection in cardiomyocytes, co-immunoprecipitation of ZBP1-cGAS-RIPK1-RIPK3 complex, STAT1 phosphorylation assays, doxorubicin cardiotoxicity model |
Cell |
High |
37352855
|
| 2023 |
A crisis-associated isoform of ZBP1 is induced by cGAS-STING signaling and binds telomeric-repeat-containing RNA (TERRA) transcripts from dysfunctional telomeres; TERRA-bound ZBP1 oligomerizes into filaments on the outer mitochondrial membrane and activates the MAVS innate immune adapter to trigger a lethal interferon response, driving replicative crisis. |
ZBP1 isoform characterization, TERRA-ZBP1 binding assays, mitochondrial membrane localization by imaging, MAVS co-immunoprecipitation, ZBP1 oligomerization assays, cGAS/STING inhibition |
Nature |
High |
36755096
|
| 2024 |
ZBP1 causes skin inflammation by inducing both RIPK3-mediated necroptosis and RIPK1-caspase-8-mediated apoptosis in keratinocytes; ZBP1-induced caspase-8-mediated inflammation requires RHIM-dependent but kinase-activity-independent RIPK1 signaling. Complete prevention of skin inflammation requires combined deficiency in MLKL and caspase-8, and no cell-death-independent inflammatory signaling by ZBP1 was detected. |
Transgenic constitutively active ZBP1 (ZBP1ca) mouse epidermis model, MLKL/caspase-8 double KO, RIPK1 kinase-dead knock-in, histopathology, cytokine measurement |
Cell death and differentiation |
High |
38849574
|
| 2024 |
STING upregulates both ZBP1 and MLKL transcriptionally; combined caspase-8 deficiency and STING-driven Z-nucleic acid accumulation activates ZBP1 and triggers formation of a ZBP1-RIPK1-RIPK3 complex independently of the FADD-RIPK1-RIPK3 complex, enabling necroptosis execution. STING and ZBP1 act as overlapping drivers of lethal dermatitis. |
Casp8E-KO mouse model, genetic deletion of STING/ZBP1/RIPK3, biochemical Co-IP of ZBP1-RIPK1-RIPK3 complex, SAVI preclinical mouse model rescue by Ripk3 co-deletion |
Nature |
High |
40834903
|
| 2024 |
RIPK1's death domain (DD) is required to restrain ZBP1-mediated necroptosis; mutation R588E in the RIPK1 DD allows ZBP1 to activate RIPK3 independently of RIPK1 kinase activity, revealing that DD-dependent oligomerization and FADD interaction determine the mechanism of RIPK3 activation by ZBP1. |
Ripk1R588E/R588E knock-in mouse genetics, biochemical mechanistic studies, RIPK3 activation assays, comparison to RHIM mutant backgrounds |
Immunity |
Medium |
38744293
|
| 2024 |
ZBP1 condensate formation via its Zαβ domain facilitates Z-nucleic acid binding and antiviral signal transduction; ZBP1 Zαβ dimerizes in a concentration-dependent manner, forms liquid-liquid phase-separated droplets upon Z-DNA/Z-RNA binding, and full-length ZBP1 forms amyloid-like puncta. RHIM domains form amyloid fibrils that cross-polymerize with RIPK1 depending on the 206IQIG209 core motif; RHIM-mutated ZBP1 impedes necroptosis. |
DLS, SAXS, in vitro condensate assays, in-cell imaging of amyloid-like puncta, RHIM domain mutagenesis, necroptosis assays in HT-29 cells, HSV/IAV infection models |
Cell death & disease |
Medium |
38982083
|
| 2025 |
Host cell-encoded Z-RNAs (not viral Z-RNAs) are major and sufficient ZBP1-activating ligands during HSV-1 and IAV infection; these Z-RNAs map to intergenic endogenous retroelements embedded in abnormally long 3' extensions of host mRNAs generated by virus-driven disruption of transcription termination (DoTT) via inhibition of CPSF. Mutant viruses lacking ICP27 or NS1 (the CPSF inhibitors) fail to induce host Z-RNA accrual and show attenuated ZBP1 activation. |
Z-RNA mapping by sequencing in HSV/IAV-infected cells, ICP27/NS1 viral mutants, ectopic expression of ICP27/NS1, pharmacological CPSF blockade, ZBP1 KO controls |
Nature |
High |
41082924
|
| 2024 |
A shorter alternatively-spliced ZBP1 isoform (ZBP1-S) containing Zα domains but lacking RHIMs acts as an endogenous inhibitor of full-length ZBP1-L by competing for Z-nucleic acid ligand binding, thereby suppressing ZBP1-L-mediated cell death and inflammation. Loss of ZBP1-S accelerates skin inflammation induced by ZBP1-mediated necroptosis. |
ZBP1-S-only knock-in mouse model, ZBP1-S KO mouse, cell death assays comparing ZBP1-S/ZBP1-L combinations, skin inflammation model |
The EMBO journal |
High |
39300211
|
| 2017 |
ZBP1 (as zipcode binding protein 1/IGF2BP1 for β-actin mRNA): the KH3-KH4 di-domain of ZBP1 mediates β-actin mRNA recognition; KH4 recognizes a non-canonical GGA sequence via an enlarged dynamic hydrophobic groove, KH3 binds a core CA sequence with low specificity. Data-informed kinetic simulation reveals the overall binding reaction is driven by the second (KH4) binding event; ZBP1 concentration modulates the interaction. |
High-resolution NMR structures of KH3-KH4 with target RNA, kinetic binding simulation, affinity measurements |
Cell reports |
High |
28147274
|
| 2007 |
ZBP1 (as zipcode binding protein 1) expression in metastatic tumor cells restores β-actin mRNA localization to lamellipodia, increases cell polarity, and reduces chemotaxis and tumor cell motility/invasion in vivo, establishing ZBP1 as a regulator of actin mRNA-dependent cell polarity. |
ZBP1 overexpression in MTLn3 cells, mRNA localization imaging, chemotaxis assays, multiphoton in vivo tumor imaging |
Journal of cell science |
Medium |
17878234
|
| 2023 |
ZBP1 senses mitochondrial Z-form DNA and interacts with RIPK1 to activate RIPK1 kinase activity, inducing transcription of pro-inflammatory molecules via NF-κB in AD microglia; deletion of Zbp1 or inhibition of RIPK1 attenuates neuroinflammation and Aβ pathology in an AD mouse model. Amyloid-β-induced oxidative stress fragments and releases mtDNA into the cytoplasm where it forms Z-DNA. |
ZBP1 KO AD mouse model, RIPK1 inhibitor, Co-IP of ZBP1-RIPK1, Z-DNA detection in microglia, Aβ pathology and behavioral assays |
Immunity |
Medium |
40902587
|
| 2013 |
DAI/ZBP1 suppresses HSV-1 replication in a DNA-sensing-independent manner requiring the Zβ and D3 domains (but not Zα). DAI colocalizes with the viral E3 ubiquitin ligase ICP0 in nuclear and cytoplasmic foci and co-immunoprecipitates with ICP0; DAI's anti-HSV-1 effect is not observed with ICP0-deleted mutant virus. |
DAI knockdown and overexpression in HepG2 cells, domain deletion mutants, co-immunoprecipitation of DAI-ICP0, viral replication assays |
Journal of virology |
Medium |
23283962
|
| 2024 |
ZBP1 is amplified by palmitic acid-activated JNK pathway in steatotic livers; upon I/R injury, excessive ROS trigger ZBP1 activation by inducing its aggregation independently of Z-nucleic acid sensing, leading to RIPK1 kinase activation and downstream apoptosis and inflammation. |
ZBP1 KO mouse steatotic liver I/R model, JNK inhibition, RIPK1 kinase inhibitor, ZBP1 aggregation assays, ROS measurement |
The Journal of clinical investigation |
Medium |
38743492
|
| 2023 |
TRIM32 is an E3 ubiquitin ligase that targets ZBP1 for proteasomal degradation; the cold-inducible RNA-binding protein CIRP competes with TRIM32 for ZBP1 binding (stabilizing ZBP1) when internalized into pulmonary endothelial cells via TLR4-mediated endocytosis during sepsis, thereby enhancing ZBP1-RIPK3-dependent PANoptosis. |
IP/MS identification of TRIM32, co-immunoprecipitation of CIRP-ZBP1 and TRIM32-ZBP1, ZBP1 ubiquitination/degradation assays, Zbp1−/− mouse sepsis model |
Military Medical Research |
Medium |
39465383
|
| 2008 |
Human ZBP1 (hZBP1) overexpression does not affect IFN-β or IL-8 production induced by intracellular bacteria or cytosolic poly(dA-dT) in human A549 cells, and multiple hZBP1 siRNAs do not suppress IFN-β responses in human cells, indicating that human ZBP1 is not required for cytosolic DNA-induced IFN-β responses in human cells (NEGATIVE FINDING for the sensor function in human cells). |
hZBP1 siRNA knockdown in human cells, hZBP1 overexpression, IFN-β reporter and ELISA assays, comparison with mouse L929 cells |
Cellular microbiology |
Medium |
18771559
|